Track 9 Meters Biopharma's income tax ($3.5M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2023
Trailing 12 months ending Mar 2023
Loading...
Loading...
As of the most recent data (March 2023), NMTR shows a income tax of $3.5M. That compares with $5.7K in the prior-year period — up 61801.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, NMTR's income tax is now $3.5M (was $5.7K) — a 61801.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether 9 Meters Biopharma is outperforming or lagging.
Tracking NMTR's income tax over time shows whether 9 Meters Biopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $3.5M That compares with $5.7K in the prior-year period — up 61801.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this income tax page, Stockcircle has 9 Meters Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect income tax (currently $3.5M) with ownership activity and broader fundamentals.
9 Meters Biopharma's income tax is $3.5M; compare it with other Technology names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.